In a significant development set to transform how life science companies and entrepreneurs secure and manage non-dilutive funding, FreeMind Group and Jameson & Company proudly announce their strategic partnership. This powerful collaboration merges FreeMind’s industry-leading expertise in securing non-dilutive funding with Jameson’s premier accounting and compliance solutions, creating an unmatched end-to-end service offering from grant proposal preparation through post-award management.

In today’s challenging economic climate, the importance of non-dilutive funding for sustaining critical life science R&D has intensified dramatically. As the 2025 federal budget was just approved with no cuts compared to 2024 and with over $48 billion allocated to NIH, over $9 billion to NSF, and sustained funding for DOD, BARDA, and other agencies, opportunities abound. However, potential changes in policy and regulations necessitate expert understanding of how funds will be allocated and how to maximize funding potential. As venture capital becomes increasingly selective and public markets remain volatile, organizations require expert guidance to identify, secure, and properly manage available funding opportunities.

The partnership establishes a comprehensive framework designed to deliver exceptional value to clients through seamlessly integrated services, aimed at maximizing not only the funding potential of each client but also of each and every submission within the known and less-known details of the regulations. Key components include sophisticated cross-service approval protocols, strategic client introductions for complementary services, coordinated marketing initiatives, and innovative educational programming tailored to the life science community’s evolving needs.

“This strategic alliance with Jameson represents a transformative advancement in our service capabilities,” said Ram May-Ron, Managing Partner of FreeMind Group. “By combining our proven grant acquisition expertise with Jameson’s specialized accounting proficiency, we’re creating an unprecedented support system that empowers life science organizations to navigate the complexities of non-dilutive funding with greater confidence, efficiency, and ultimately, success.”

Ed Jameson, Managing Member of Jameson & Company, emphasized the client-focused benefits: “Our partnership with FreeMind enables us to deliver truly integrated solutions that address the entire funding lifecycle. This collaboration allows us to create customized, streamlined approaches that not only meet but anticipate the unique challenges facing each client. Together, we’re establishing new benchmarks for excellence in non-dilutive funding support services.”

The alliance will immediately launch a series of specialized webinars and educational initiatives focused on demystifying compliance requirements and optimizing financial management strategies for non-dilutive funding recipients.

This groundbreaking partnership represents a significant advancement in providing life science organizations with a holistic, expert-driven approach to grant funding and financial compliance, ultimately enhancing operational efficiency and dramatically improving grant success rates at a time when maximizing every funding opportunity is more crucial than ever.

About FreeMind:

Founded in 1999, FreeMind Group is the leading consulting firm specializing in securing non-dilutive funding for life science organizations. With a proven track record of success, FreeMind has helped its clients secure over $2 billion in funding to date, with annual awards exceeding $100 million. The firm works with R&D-stage companies across the life sciences sector, from startups to large organizations, including academia and industry.

FreeMind’s expertise spans the full spectrum of U.S. government funding mechanisms, including NIH, DoD, BARDA, NSF, and FDA, as well as private foundations. The firm’s dedicated team of Strategists and Grant Consultants guide clients through every stage of the funding process—from identifying the most suitable opportunities to submission and award.

Leveraging a proprietary AI-powered platform, Granti, FreeMind enhances the efficiency and quality of complex grant applications, optimizing outcomes for its clients. Through a long-term, multi-submission strategic approach, FreeMind makes non-dilutive funding a central pillar of its clients’ financial strategy, empowering them to advance groundbreaking research and innovation.

For more information, visit https://freemindgroup.com/

About Jameson & Company

Founded in 1978, Jameson & Company is a leading CPA firm specializing in the complex financial and compliance aspects of government grants and contracts for life science and technology companies. Jameson has helped thousands of clients navigate the financial challenges of non-dilutive funding, ensuring compliance with federal regulations while maximizing financial efficiency.

Jameson & Company provides expert accounting, indirect rate strategy, audit readiness, and financial management services tailored to organizations receiving funding from agencies such as NIH, DoD, NSF, BARDA, and more. The firm’s in-depth understanding of federal cost principles and agency regulatory requirements helps clients avoid costly pitfalls and remain audit-ready while focusing on innovation and growth.

Over the past 47 years, Jameson has developed deep industry expertise with a client-centric approach empowering organizations to secure, manage, and survive audit on more than $6 billion in government funding awards.

For more information, visit https://www.jamesoncpa.com/